Immunic (NASDAQ:IMUX) Given “Outperform” Rating at William Blair
William Blair reissued their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research report report published on Friday morning,RTT News reports. Other analysts have also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and set a $10.00 price target on shares of Immunic in a research […]
William Blair reissued their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research report report published on Friday morning,RTT News reports. Other analysts have also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and set a $10.00 price target on shares of Immunic in a research […]
